Description

▪ Introduction

Clentil 60 mcg by Novotex Pharma contains Clenbuterol Hydrochloride, a β2-adrenergic agonist originally developed for medical treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions due to its bronchodilatory effects. Clenbuterol has been extensively studied for its thermogenic properties, supporting metabolic rate increase and lipolysis, making it relevant for research on respiratory health and metabolic regulation.

Manufactured under strict pharmaceutical-grade standards, Clentil 60 mcg tablets ensure precise dosing and consistency. Packaged in bottles containing 100 tablets, this product is intended exclusively for laboratory and analytical use.

▪ Product Details (Bulleted)

• Active Ingredient: Clenbuterol Hydrochloride

• Concentration per Tablet: 60 mcg

• Form: Oral tablets

• Package Size: 100 tablets per bottle

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Clenbuterol exhibits a half-life of approximately 25–39 hours, supporting once-daily dosing in clinical settings. It acts on β2-adrenergic receptors to promote smooth muscle relaxation in the airways and stimulates thermogenesis and lipolysis, relevant for metabolic and respiratory research.

▪ Usage Recommendations

• Typical Medical Dosage (historic use): 20–40 mcg daily, titrated based on respiratory response under medical supervision

• Current Use: For laboratory and research applications only

• Administration Route: Oral ingestion

• Use Statement: Strictly for laboratory and analytical use only

▪ Disclaimer

This product is intended solely for laboratory research and analytical use. It is not approved for human therapeutic use or consumption. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with pre-existing health conditions. Always adhere to local regulations and professional research guidelines.